share_log

Why Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket

Why Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket

为什么 Reata Pharmicals 的股价上涨了 140%；这里有 20 只股票在盘前走势
Benzinga ·  2023/03/01 21:00

Gainers

获胜者

  • Reata Pharmaceuticals Inc (NASDAQ:RETA) rose 140.8% to $75.06 in pre-market trading after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.
  • OncoSec Medical Incorporated (NASDAQ:ONCS) rose 75.9% to $1.90 in pre-market trading after the company requests withdrawal of registration statement, The company said it has opted not to pursue offering thereby at this time.
  • Lionheart III Corp (NASDAQ:LION) shares rose 56.2% to $22.80 in pre-market trading after jumping around 98% on Tuesday.
  • China Pharma Holdings Inc (NASDAQ:CPHI) rose 20.8% to $0.081 in pre-market trading. China Pharma recently announced a 1-for-10 reverse stock split.
  • Helbiz Inc (NASDAQ:HLBZ) rose 19.1% to $0.17 in pre-market trading after gaining over 21% on Tuesday.
  • Sarepta Therapeutics Inc (NASDAQ:SRPT) rose 17% to $142.90 in pre-market trading after the company reported better-than-expected Q4 results.
  • Landos Biopharma Inc (NASDAQ:LABP) shares rose 14.9% to $0.43 in pre-market trading. Landos Biopharma announced transfer of LANCL portfolio, including Omilancor, LABP-104 and LABP-111 to Landos' founder.
  • China SXT Pharmaceuticals Inc (NASDAQ:SXTC) rose 14.7% to $0.45 in pre-market trading after gaining over 3% on Tuesday.
  • Cerevel Therapeutics Holdings Inc (NASDAQ:CERE) rose 9.7% to $29.30 in pre-market trading. Cerevel Therapeutics recently posted a narrower-than-expected quarterly loss.
  • Bilibili Inc - ADR (NASDAQ:BILI) shares rose 8.8% to $21.00 in pre-market trading after dropping over 3% on Tuesday.
  • 瑞塔制药公司 纳斯达克股票代码：RETA）在盘前交易中上涨140.8％，至75.06美元，此前该公司报告说，美国食品药品管理局已批准SKYCLARYS治疗弗里德赖希共济失调患者。
  • OncoSec 医疗公司 纳斯达克股票代码：ONCS）在要求撤回注册声明后，在盘前交易中上涨75.9％，至1.90美元。该公司表示，目前已选择不就此进行发行。
  • 狮心三世公司 纳斯达克股票代码：LION）股价在周二上涨约98％后，在盘前交易中上涨了56.2％，至22.80美元。
  • 中国医药控股有限公司 纳斯达克股票代码：CPHI）在盘前交易中上涨20.8％，至0.081美元。中国制药最近宣布了1比10的反向股票分割。
  • Helbiz Inc 纳斯达克股票代码：HLBZ）在周二上涨超过21％后，在盘前交易中上涨19.1％，至0.17美元。
  • 萨雷普塔疗法公司 纳斯达克股票代码：SRPT）在盘前交易中上涨了17％，至142.90美元，此前该公司公布的第四季度业绩好于预期。
  • 兰多斯生物制药公司 纳斯达克股票代码：LABP）的股价在盘前交易中上涨了14.9％，至0.43美元。Landos Biopharma宣布将包括Omilancor、LABP-104 和 LABP-111 在内的LANCL投资组合转让给Landos的创始人。
  • 中国苏轩堂药业有限公司 纳斯达克股票代码：SXTC）在周二上涨超过3％后，在盘前交易中上涨14.7％，至0.45美元。
  • Cerevel Therapeutic 纳斯达克股票代码：CERE）在盘前交易中上涨9.7％，至29.30美元。Cerevel Therapeutics最近公布的季度亏损低于预期。
  • Bilibili Inc-ADR 纳斯达克股票代码：BILI）股价在周二下跌超过3％后，在盘前交易中上涨8.8％，至21.00美元。

Losers

失败者

  • OKYO Pharma (NASDAQ:OKYO) fell 24.2% to $1.69 in pre-market. US Customs cleared OKYO Pharma's GMP packaged OK-101 drug for Phase 2 clinical trial for treating dry eye disease.
  • Novavax Inc (NASDAQ:NVAX) fell 24% to $7.04 in pre-market trading after the company reported worse-than-expected Q4 results and said substantial doubt exists regarding its ability to continue as a going concern.
  • Marqeta Inc (NASDAQ:MQ) fell 19.1% to $4.69 in pre-market trading after the company reported fourth-quarter results and issued guidance for slowing growth.
  • Beamr Imaging Ltd. (NASDAQ:BMR) shares fell 18.6% to $2.97 in pre-market trading. Beamr Imaging priced its initial public offering of 1,950,000 at a public offering price of $4.00 per share.
  • Obseva SA (NASDAQ:OBSV) shares dropped 15.2% to $0.12 in pre-market trading after jumping 43% on Tuesday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.
  • Brightspire Capital Inc (NYSE:BRSP) fell 14.4% to $6.32 in pre-market trading after the company announced an offering of 30,358,213 shares by DigitalBridge Group, Inc.
  • Performance Shipping Inc (NASDAQ:PSHG) fell 13% to $2.34 in pre-market trading. Performance Shipping announced termination of at-the-market offering.
  • Grove Collaborative Holdings Inc (NYSE:GROV) fell 12.7% to $0.38 in pre-market trading.
  • Catalyst Biosciences Inc (NASDAQ:CBIO) fell 11.4% to $0.26 in pre-market trading. Catalyst Biosciences shares jumped around 24% on Tuesday after GC Biopharma signed an Asset Purchase Agreement with the company.
  • AMC Entertainment Holdings Inc (NYSE:AMC) shares fell 8.5% to $6.53 in pre-market trading after the company posted Q4 results. The company ended the quarter with available liquidity of $842.7 million and debt of $4.95 billion.
  • OKYO 制药 纳斯达克股票代码：OKYO）盘前下跌24.2％，至1.69美元。美国海关批准了 OKYO Pharma 的 GMP 包装的 OK-101 药物用于治疗干眼病的 2 期临床试验。
  • Novavax Inc. 纳斯达克股票代码：NVAX）在盘前交易中下跌24％，至7.04美元，此前该公司公布的第四季度业绩低于预期，并表示其继续作为持续经营企业的能力存在重大疑问。
  • Marqeta Inc 纳斯达克股票代码：MQ）在盘前交易中下跌19.1％，至4.69美元，此前该公司公布了第四季度业绩并发布了增长放缓的指导方针。
  • Beamr Imaging 有限公司 纳斯达克股票代码：BMR）股价在盘前交易中下跌18.6％，至2.97美元。Beamr Imaging将其195万美元的首次公开募股定价为每股4.00美元。
  • Obseva SA 纳斯达克股票代码：OBSV）股价在周二上涨43％后，在盘前交易中下跌了15.2％，至0.12美元。Obseva最近宣布了战略重组，以整合在瑞士的业务。
  • Brightspire Capital公司 纽约证券交易所代码：BRSP）在盘前交易中下跌14.4％，至6.32美元，此前该公司宣布DigitalBridge Group, Inc.发行30,358,213股股票。
  • 高性能航运公司 纳斯达克股票代码：PSHG）在盘前交易中下跌13％，至2.34美元。Performance Shipping宣布终止在市场上发行
  • 格罗夫合作控股公司 纽约证券交易所代码：GROV）在盘前交易中下跌12.7％，至0.38美元。
  • Catalyst 生物科学公司 纳斯达克股票代码：CBIO）在盘前交易中下跌11.4％，至0.26美元。在GC Biopharma与公司签署资产购买协议后，Catalyst Biosciences的股价周二上涨了约24％。
  • AMC 娱乐控股公司 纽约证券交易所代码：AMC）公布第四季度业绩后，股价在盘前交易中下跌8.5％，至6.53美元。该公司在本季度末的可用流动性为8.427亿美元，债务为49.5亿美元。

Now Read This: Top 5 Health Care Stocks That You May Want To Dump In Q1 2023

现在读这个： 你可能想在 2023 年第一季度抛售的前 5 只医疗保健股

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发